Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
---|
Total Revenue
|
17,762,000
|
14,605,000
|
14,111,000
|
15,691,000
| Cost of Revenue |
-
|
-
|
-
|
-
| |
Gross Profit
|
17,762,000
|
14,605,000
|
14,111,000
|
15,691,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 12,629,000 | 14,064,000 | 12,445,000 | 12,348,000 |
|
Non Recurring | 3,452,000 | 4,411,000 | 6,642,000 | 3,257,000 |
|
Others | 2,309,000 | 2,980,000 | 2,470,000 | 2,592,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
5,103,000
|
692,000
|
(1,579,000)
|
3,429,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 450,000 | 438,000 | 615,000 | 273,000 |
|
Earnings Before Interest And Taxes | 9,834,000 | 5,758,000 | 3,912,000 | 9,143,000 |
|
Interest Expense | 4,281,000 | 4,628,000 | 4,876,000 | 5,441,000 |
|
Income Before Tax | 5,553,000 | 1,130,000 | (964,000) | 3,702,000 |
|
Income Tax Expense | 1,588,000 | (206,000) | (1,488,000) | 715,000 |
|
Minority Interest | (90,000) | (28,000) | (25,000) | (40,000) |
|
|
|
Net Income From Continuing Ops | 3,965,000 | 1,336,000 | 524,000 | 2,987,000 | |
|
Non-recurring Events |
|
Discontinued Operations | (67,000) | (112,000) | (31,000) | (1,000) |
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
3,808,000
|
1,196,000
|
468,000
|
2,946,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
3,808,000
|
1,196,000
|
468,000
|
2,946,000
|
|